Elbit Medical Technologies Ltd (EMTC-M.TA)
ILA 24.2
(0.0%)
ILA 24.2
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 7.41 Million USD | -70.96% |
| 2022 | 25.53 Million USD | -17.89% |
| 2021 | 31.09 Million USD | -62.55% |
| 2020 | 83.02 Million USD | 501.83% |
| 2019 | 13.79 Million USD | -50.78% |
| 2018 | 28.03 Million USD | 31044.44% |
| 2017 | 90 Thousand USD | -98.38% |
| 2016 | 5.54 Million USD | -73.1% |
| 2015 | 20.62 Million USD | -38.55% |
| 2014 | 33.56 Million USD | -17.6% |
| 2013 | 40.72 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 7.81 Million USD | 5.4% |
| 2024 Q2 | 7.81 Million USD | 0.0% |
| 2023 Q2 | 22.71 Million USD | 0.0% |
| 2023 FY | 7.41 Million USD | -70.96% |
| 2023 Q4 | 7.41 Million USD | 0.0% |
| 2023 Q3 | 7.41 Million USD | -67.36% |
| 2023 Q1 | 22.71 Million USD | -11.05% |
| 2022 Q4 | 25.53 Million USD | 0.0% |
| 2022 Q1 | 26.69 Million USD | -14.16% |
| 2022 Q2 | 26.69 Million USD | 0.0% |
| 2022 FY | 25.53 Million USD | -17.89% |
| 2022 Q3 | 25.53 Million USD | -4.35% |
| 2021 Q2 | 77.61 Million USD | -3.25% |
| 2021 FY | 31.09 Million USD | -62.55% |
| 2021 Q4 | 31.09 Million USD | 0.0% |
| 2021 Q1 | 80.22 Million USD | -3.38% |
| 2021 Q3 | 31.09 Million USD | -59.93% |
| 2020 Q4 | 83.02 Million USD | 13.45% |
| 2020 FY | 83.02 Million USD | 501.83% |
| 2020 Q1 | 92.71 Million USD | 572.04% |
| 2020 Q2 | 79.09 Million USD | -14.69% |
| 2020 Q3 | 73.18 Million USD | -7.47% |
| 2019 Q3 | 14.04 Million USD | -13.39% |
| 2019 Q2 | 16.21 Million USD | -49.38% |
| 2019 FY | 13.79 Million USD | -50.78% |
| 2019 Q1 | 32.02 Million USD | 14.26% |
| 2019 Q4 | 13.79 Million USD | -1.74% |
| 2018 FY | 28.03 Million USD | 31044.44% |
| 2018 Q2 | 6.77 Million USD | 0.0% |
| 2018 Q1 | - USD | -100.0% |
| 2018 Q4 | 28.03 Million USD | 0.0% |
| 2017 FY | 90 Thousand USD | -98.38% |
| 2017 Q1 | 1.71 Million USD | -69.02% |
| 2017 Q2 | 1.71 Million USD | 0.0% |
| 2017 Q3 | 90 Thousand USD | -94.76% |
| 2017 Q4 | 90 Thousand USD | 0.0% |
| 2016 FY | 5.54 Million USD | -73.1% |
| 2016 Q4 | 5.54 Million USD | -50.13% |
| 2016 Q3 | 11.12 Million USD | -18.14% |
| 2016 Q2 | 13.59 Million USD | -20.08% |
| 2016 Q1 | 17 Million USD | -17.55% |
| 2015 FY | 20.62 Million USD | -38.55% |
| 2015 Q1 | 29.09 Million USD | -13.32% |
| 2015 Q2 | 25.38 Million USD | -12.74% |
| 2015 Q3 | 22.44 Million USD | -11.56% |
| 2015 Q4 | 20.62 Million USD | -8.13% |
| 2014 Q1 | 38.54 Million USD | -5.35% |
| 2014 Q3 | 34.38 Million USD | 0.13% |
| 2014 Q4 | 33.56 Million USD | -2.41% |
| 2014 Q2 | 34.34 Million USD | -10.91% |
| 2014 FY | 33.56 Million USD | -17.6% |
| 2013 Q4 | 40.72 Million USD | -1.25% |
| 2013 Q3 | 41.24 Million USD | -1.0% |
| 2013 Q1 | 43.34 Million USD | 0.0% |
| 2013 FY | 40.72 Million USD | 0.0% |
| 2013 Q2 | 41.65 Million USD | -3.89% |
| Name | Total Assets | Total Assets Difference |
|---|